With the use of mouselymphoma and melanoma models, we demonstrated that elimination of CD47 expression from tumor antigen-expressing normal cells or tumor cells by genetic deletion or antibody blocking significantly improved the effectiveness of whole tumor cell vaccination. Here, CD47 is linked to neoplasm.